Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Topotecan × Clear all

Sponsor

Conditions

Ovarian Neoplasms 26 Small Cell Lung Carcinoma 21 Neuroblastoma 12 Fallopian Tube Neoplasms 12 Uterine Cervical Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Lung Neoplasms 6 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Leukemia, Myeloid, Acute 3 Ganglioneuroblastoma 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Small Cell 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Retinoblastoma 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peritoneal Neoplasms 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡